How Sahm Adrangi’s Kerrisdale Capital Management is Ripping Benefits from Short-selling Stocks

Investors of Kerrisdale Capital Management recently placed a bet on a single share of Kerrisdale’s unnamed company. The bet amounted to $100. Kerrisdale Capital, which was created by Sahm Adrangi, is now regarded as the first hedge fund manager to raise such a fund. Hedge fund managers refer the fund to as a “co-investment” fund. Kerrisdale plans to utilize the fund in shorting a single stock of the soon-to-be-announced publicly-traded company.

Sahm Adrangi wrote to the investors regarding his firm’s future business objectives. He told them that his company made history when it raised a huge amount of money in a short time. He also informed them that Kerrisdale is on a mission to let everyone understands its present and plans. In reference to the email Adrangi sent to investors, Kerrisdale Capital is reported to be worth over $10 billion.

Besides Sahm Adrangi, Kerrisdale’s management team also comprises of an analyst by the name Shane Wilson. Adrangi and Wilson have joined forces to develop an informative campaign targeting Kerrisdale’s clients, investors, and partners. This campaign is expected to be amplified by a new website, video, and report.

Kerrisdale Capital Management currently has assets with a worth of $500 million under its belt. The company has gained critically-acclaim severally for inviting investors to bet against publicly-traded companies. Among the companies that Kerrisdale’s investors betted on include Zagfen and Sage Therapeutics. Kerrisdale Capital earns yearly returns of over 28 percent of the betted stocks.

About Sahm Adrangi

Sahm Adrangi has been part of Kerrisdale’s investment management operations as the chief investment officer. His strengths lie in shorting stocks and carrying out short-selling research. Adrangi also earned popularity due to his efforts to expose firms that failed to abide by the regulations of the SEC. These companies included China-Biotics and China Cast Education Corporation.

Through Kerrisdale Capital Management, Sahm Adrangi carries out and shares research on the mining and biotechnology sectors. His recent research interests were on biotech companies like Zafgen, Pulse Biosciences, and Bavarian Nordic. In the mining sector, he has focused on companies like Northern Dynasty Minerals and First Majestic Silver. He also shares his views regarding telecom companies like Path Communications, Dish Network, Viasat, and Globalstar.

Jason Hope Search for Anti-Aging Disease Cure

Despite the advanced technology used in the current millennium, there’s still very little research on age-related diseases. However, Jason Hope, an Arizona based entrepreneur is using his fund to sponsor research on anti-aging ailments. He has focused his philanthropic might to SENS; a nonprofit organization developed in 2009 with the sole purpose of investigating age-related diseases. SENS has been using regenerative biotechnology as the basis of their research.

In 2010, Jason Hope donated half a million to SENS to build a Cambridge laboratory that would implement the finding of the diseases. Over the years he has also funded the organization further thus underlining his commitment to the course. Jason opted to invest in SENS because Jason has faith in the research they are conducting and believes that the attempts will change the healthcare industry in years to come. He information generated will have huge impacts in the pharmaceutical and biotech companies in the future. For the SENS, the institute to grow, it requires combined efforts from as many people as possible. Jason has taken upon himself to initiate outreach programs rather than being the sole contributor.

The approach in the rejuvenated technology is visionary because it is attempting to treat the diseases while enhancing more understanding on the topic. Research in rejuvenation will help extend the lifespan and create a quality life experience for the aging. According to the study, aging is due to damaged cells from healthy metabolism, and this further creates an opening for attack by diseases. SENS is, therefore, working on repairing damaged cells with much efficiency to counter the effects of metabolism.

The program efforts have picked the interests of various individuals in the on the notable contributor is the founder of PayPal, Peter Thiel who has donated a reasonable amount to the research. SENS is the brainchild of Aubrey de Gray a Ph.D. holder who is famous for his research on aging. De gray has been able to bring out his ideas about aging in a perspective which other scientist hadn’t considered. He has also been a critical contributor to the organization’s finances along with the founders of Google.

Jason Hope was born and raised in Arizona. He earned a finance degree from Arizona State University and had a second degree from Carey school of business at Arizona state university. He has built his reputation along with his futuristic investment ways. Jason Hope has an immense curiosity about the tech world and hopes to challenge the modern methods of scientific research. He resides in Scottsdale Arizona and spends most of his earning on philanthropy.

Jason Hope Info: